To this end, we prepared Ca-Gly BioMOF nanoparticles modified with an anti-VEGFR1 scFv fragment and determined the toxicity, apoptotic effects and cellular uptake by cellular assays and fluorescence microscopy on cancer cell lines. The gene discussed is FLT1; the disease is cancer.